Comparison of 'time within therapeutic INR range' with 'percentage INR within therapeutic range' for assessing long-term anticoagulation control in children

被引：11
|
作者：
Biss, T. T. [1 ]
Avery, P. J. [2 ]
Walsh, P. M. [3 ]
Kamali, F. [1 ]
机构：
[1] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Newcastle Upon Tyne Hosp NHS Trust, Dept Paediat Cardiol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷 / 05期
关键词：
WARFARIN MANAGEMENT; PEDIATRIC-PATIENTS; SELF-MANAGEMENT; COHORT; HOME;
D O I：
10.1111/j.1538-7836.2011.04248.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1090 / 1092
页数：3
相关论文
共 50 条
  • [31] INR Remote Monitoring is Associated with Improved Time in Therapeutic Range Following Left Ventricular Assist Device Implantation
    Nguyen, V. N.
    Smith, M.
    Belyk, M.
    Brambatti, M.
    Braun, O. O.
    Adler, E. D.
    Mariski, M.
    Stevens, C.
    Feist, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S309 - S309
  • [32] Evaluation of warfarin dose and INR time in therapeutic range in left ventricular assist device patients with sleeve gastrectomy
    Robertson, Stephanie
    Weeks, Phillip
    Chow, Elaine
    Gulbis, Brian
    Nathan, Sriram
    Patarroyo-Aponte, Maria
    Gregoric, Igor
    Shah, Shinil K.
    Bajwa, Kulvinder S.
    Kar, Biswajit
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2025, 48 (02): : 77 - 83
  • [33] Impact Of Narrow Versus Wide INR Goal On Time In Therapeutic Range In Patients With Left Ventricular Assistive Devices
    Choi, Myoung hyun
    Azari, Zubeen
    Okon, Natalia
    Negrelli, Jenna m
    Newman, Joshua
    Yu, Mingxi dennis
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [34] Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations in Renal Transplant Recipients.
    Khalil, K.
    West-Thielke, P.
    Lichvar, A.
    Benedetti, E.
    Patel, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 797 - 798
  • [35] THE EFFECT ON SEIZURE CONTROL OF ADJUSTING PLASMA PHENYTOIN WITHIN THE THERAPEUTIC RANGE
    FEELY, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (04) : P627 - P628
  • [36] Adequate time in therapeutic INR range using triple antithrombotic therapy is not associated with long-term cardiovascular events and major bleeding complications after drug-eluting stent implantation
    Konishi, Hirokazu
    Miyauchi, Katsumi
    Kasai, Takatoshi
    Tsuboi, Shuta
    Ogita, Manabu
    Naito, Ryo
    Dohi, Tomotaka
    Tamura, Hiroshi
    Okazaki, Shinya
    Daida, Hiroyuki
    JOURNAL OF CARDIOLOGY, 2016, 68 (5-6) : 517 - 522
  • [37] Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin
    Ting, Clara
    Sylvester, Katelyn W.
    Schurr, James W.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 : 178S - 181S
  • [38] Quality of management of oral anticoagulation as assessed by time in therapeutic INR range in elderly and younger patients with low mean years of formal education: a prospective cohort study
    de Barros Costa, Gustavo Lamego
    Ferreira, Diana Carvalho
    Valacio, Reginaldo Aparecido
    Vieira Moreira, Maria da Consolacao
    AGE AND AGEING, 2011, 40 (03) : 375 - 381
  • [39] Anticoagulation control in Malaysia: Reports of time in therapeutic range, bleeding, and thromboembolic complications
    Mazlan-Kepli, W.
    Mohamed, S.
    Nik-Ismail, N. A.
    Nagarajah, J. R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 369 : 12 - 12
  • [40] Warfarin monitoring with the Fiix-prothrombin time (Fiix-INR) increases time within target range and reduces dose adjustment need compared to standard monitoring using INR
    Onundarson, P. T.
    Arnar, O. D.
    Bjornsson, E.
    Magnusson, M. K.
    Indridason, S.
    Einarsdottir, K. A.
    Magnusdottir, G.
    Vidarsson, B.
    Francis, C. W.
    Gudmundsdottir, B. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 467 - 468
12345